Clinical Trial Update: ZOSTAVAX(R) Local Registration Trial (V211-019) [Phase 3]

View source ↗

Summary

Phase 3 trial update for ZOSTAVAX in Varicella virus infection (NCT00444860) with status COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Zostavax (Varicella zoster vaccine live)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Varicella Virus Infection | Phase 3 | Status: COMPLETED